These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28330929)

  • 41. The roles of ubiquitin modifying enzymes in neoplastic disease.
    Kumari N; Jaynes PW; Saei A; Iyengar PV; Richard JLC; Eichhorn PJA
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):456-483. PubMed ID: 28923280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sumoylation Pathway as Potential Therapeutic Targets in Cancer.
    Gong L; Qi R; Li DW
    Curr Mol Med; 2017; 16(10):900-905. PubMed ID: 28017138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of Serotonin 1A Receptor SUMOylation by SENP2 and PIASxα.
    Gupta S; Wang M; Azuma Y; Muma NA
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Writing and erasing MYC ubiquitination and SUMOylation.
    Chen Y; Sun XX; Sears RC; Dai MS
    Genes Dis; 2019 Dec; 6(4):359-371. PubMed ID: 31832515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ZMIZ proteins: partners in transcriptional regulation and risk factors for human disease.
    Lomelí H
    J Mol Med (Berl); 2022 Jul; 100(7):973-983. PubMed ID: 35670836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The implication of the SUMOylation pathway in breast cancer pathogenesis and treatment.
    Rabellino A; Khanna KK
    Crit Rev Biochem Mol Biol; 2020 Feb; 55(1):54-70. PubMed ID: 32183544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PIAS adds methyl-bias to HSC-differentiation.
    Ghaffari S
    EMBO J; 2014 Jan; 33(2):93-5. PubMed ID: 24421322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis.
    Esposito JE; De Iuliis V; Avolio F; Liberatoscioli E; Pulcini R; Di Francesco S; Pennelli A; Martinotti S; Toniato E
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caspar SUMOylation regulates
    Kaduskar B; Trivedi D; Ratnaparkhi GS
    MicroPubl Biol; 2020 Aug; 2020():. PubMed ID: 32760885
    [No Abstract]   [Full Text] [Related]  

  • 50. SUMOylation inhibitor activates immune response.
    Crunkhorn S
    Nat Rev Drug Discov; 2021 Nov; 20(11):816. PubMed ID: 34611333
    [No Abstract]   [Full Text] [Related]  

  • 51. Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres.
    Salsman J; Rapkin LM; Margam NN; Duncan R; Bazett-Jones DP; Dellaire G
    Cell Death Dis; 2017 Mar; 8(3):e2724. PubMed ID: 28358373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
    Groner B; von Manstein V
    Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX.
    Delbarre E; Ivanauskiene K; Spirkoski J; Shah A; Vekterud K; Moskaug JØ; Bøe SO; Wong LH; Küntziger T; Collas P
    Genome Res; 2017 Jun; 27(6):913-921. PubMed ID: 28341773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA Damage Tolerance Pathway Choice Through Uls1 Modulation of Srs2 SUMOylation in
    Kramarz K; Mucha S; Litwin I; Barg-Wojas A; Wysocki R; Dziadkowiec D
    Genetics; 2017 May; 206(1):513-525. PubMed ID: 28341648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.
    Seif F; Khoshmirsafa M; Aazami H; Mohsenzadegan M; Sedighi G; Bahar M
    Cell Commun Signal; 2017 Jun; 15(1):23. PubMed ID: 28637459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SUMO conjugation to spliceosomal proteins is required for efficient pre-mRNA splicing.
    Pozzi B; Bragado L; Will CL; Mammi P; Risso G; Urlaub H; Lührmann R; Srebrow A
    Nucleic Acids Res; 2017 Jun; 45(11):6729-6745. PubMed ID: 28379520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of transcription factors by sumoylation.
    Rosonina E; Akhter A; Dou Y; Babu J; Sri Theivakadadcham VS
    Transcription; 2017 Aug; 8(4):220-231. PubMed ID: 28379052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Small-Molecule Microarray Approach for the Identification of E2 Enzyme Inhibitors in Ubiquitin-Like Conjugation Pathways.
    Zlotkowski K; Hewitt WM; Sinniah RS; Tropea JE; Needle D; Lountos GT; Barchi JJ; Waugh DS; Schneekloth JS
    SLAS Discov; 2017 Jul; 22(6):760-766. PubMed ID: 28346086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Proteomic Approach to Identify Alterations in the Small Ubiquitin-like Modifier (SUMO) Network during Controlled Mechanical Ventilation in Rat Diaphragm Muscle.
    Namuduri AV; Heras G; Mi J; Cacciani N; Hörnaeus K; Konzer A; Lind SB; Larsson L; Gastaldello S
    Mol Cell Proteomics; 2017 Jun; 16(6):1081-1097. PubMed ID: 28373296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance.
    Anantha RW; Simhadri S; Foo TK; Miao S; Liu J; Shen Z; Ganesan S; Xia B
    Elife; 2017 Apr; 6():. PubMed ID: 28398198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.